| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jul―03 |
Translational Analysis of Cytokine SNPs Reveals an Interplay Between Immune Response and Glucose Metabolism Following Mild-to-Moderate COVID-19 |
Nipaporn Teerawattanapong, Ganyalak Chaimaha, Tassanee Narkdontri, Suavaluk Songlilitchuwong, Saranya Innang, Sarocha Suthon, Watip Tangjittipokin |
| 2 |
[GO] |
2025―Feb―14 |
Suppression of miR-155 Attenuates Lung Cytokine Storm Induced by SARS-CoV-2 Infection |
Dharmendra Kumar Soni, Juan Cabrera-Luque, Swagata Kar, Anwar Ahmed, Chaitali Sen, Joseph Devaney, Roopa Biswas |
| 3 |
[GO] |
2024―Sep―20 |
Integrated Analysis of Noncoding RNAs (PVT-1 and miR-200c) and Their Correlation with STAT4/IL-6 Axis as Reliable Biomarkers for COVID-19 Severity |
Ghada Ayeldeen, Bahaa Mohammed Badr, Mohamed R. Herzalla, Eman Amer, Mahmoud Elsabahy, Olfat G. Shaker, Nabil A. Hasona |
| 4 |
[GO] |
2024―Jul―01 |
Cytokine Signatures and Immune Dysregulation in COVID-19 Patients: Transcriptomic and Serum Analysis |
Nikola Ralchev, Silviya Lyubenova Bradyanova, Yana Valerieva Doneva, Nikolina Mihaylova, Elena Vikentieva Elefterova-Florova, Andrey Ivanov Tchorbanov, José Francisco Muñoz-Valle, Maria Cristina Petralia, Ferdinando Nicoletti, Paolo Fagone |
| 5 |
[GO] |
2024―May―13 |
The Effects of Convalescent Plasma Transfusion on Serum Levels of Macrophage-Associated Inflammatory Biomarkers in Patients with Severe COVID-19 |
Mojtaba Shohan, Mohammad Reza Mahmoudian-Sani, Ali Saeedi-Boroujeni, Sara Iranparast, Roohangiz Nashibi, Farhad Abolnezhadian, Farid Yousefi, Seyed Mohammad Alavi, Bahman Cheraghian, Ali Khodadadi |
| 6 |
[GO] |
2024―Apr―10 |
Pharmacodynamic of Recombinant Human Interferon Alpha-2b Nasal Drops and Effective Prophylaxis Against SARS-COV-2 Infection |
Hugo Nodarse-Cuni, Odalys Bravo, Roberto Cañete, Dania Vázquez-Blomquist, Diogenes Quintana, Ana Aguilera-Barreto, Gerardo Guillen-Nieto, Amaylid Arteaga, Ileana Morales |
| 7 |
[GO] |
2024―Apr―01 |
The Effective Inhibitory Concentration of Interferon-β Correlates with Infectivity and Replication Fitness of SARS-CoV-2 Variants |
Janmejay Singh, Anbalagan Anantharaj, Parveen Kumar, Rajesh Pandey, Anil Kumar Pandey, Guruprasad R. Medigeshi |
| 8 |
[GO] |
2023―Dec―28 |
Association of Polymorphisms of the IL-17A and IL-17F Genes with Increased Risk of Hypertension and Obesity in Mexican Patients with COVID-19 |
Richard Salama-Frisbie, Cinthia A. Molina-Flores, Arguiñe I. Urraza-Robledo, María E. Gutiérrez-Pérez, Alberto A. Miranda-Pérez, Alhi A. Gutiérrez-Salas, Jorge Haro-Santa Cruz, Francisco C. López-Márquez |
| 9 |
[GO] |
2023―Dec―04 |
BioHabana 2022: Preventive and Immunotherapeutic Strategies Against COVID-19 and Cancer in Cuba |
Iraldo Bello-Rivero, Tania Crombet-Ramos, Circe Mesa-Pardillo, Yanelys Morera-Díaz, Zaima Mazorra-Herrera, Dagmar Garcia-Rivera, Hugo Nodarse-Cuní, Francisco Hernández-Bernal, Verena Muzio-Gonzalez, Ana Aguilera-Barreto, Dania Vazquez-Blomquist, Maria del Carmen Domínguez-Horta, Gerardo Guillen-Nieto |
| 10 |
[GO] |
2023―Oct―31 |
High Anti-Interferon-Alpha Autoantibody Levels in Severe/Critical COVID-19 Patients from Peru |
Maria J. Pons, Ana Mayanga-Herrera, Luciano A. Palomino-Kobayashi, Antonio M. Quispe, Manuel F. Ugarte-Gil |
| 11 |
[GO] |
2023―Sep―14 |
Characterization of IL-10 Family of Cytokines in Acute and Convalescent COVID-19 Individuals |
Anuradha Rajamanickam, Pavan Kumar Nathella, Nandhini Selvaraj, Murhekar Manoj, Jeromie Wesley Vivian Thangaraj, Santhosh Kumar Muthusamy, Girish Kumar Chethrapilly Purushothaman, Tarun Bhatnagar, Manickam Ponnaiah, Sabarinathan Ramasamy, Saravanakumar Velusamy, Subash Babu |
| 12 |
[GO] |
2023―Aug―11 |
Correction to: A Specific Pattern and Dynamics of Circulating Cytokines Are Associated with the Extension of Lung Injury and Mortality in Colombian Adults with Coronavirus Disease-19, by Sara Bolívar-Marín, et al. J Interferon Cytokine Res 2023; (vol. 43, no. 5; 206-215); doi: 10.1089/jir.2023.0001 |
|
| 13 |
[GO] |
2023―Jun―29 |
Altered Tumor Necrosis Factor Response in Neurologic Postacute SARS-CoV-2 Syndrome |
Lao-Tzu Allan-Blitz, Jesse Goodrich, Howard Hu, Omid Akbari, Jeffrey D. Klausner |
| 14 |
[GO] |
2023―May―30 |
COVID-19 Severity Shifts the Cytokine Milieu Toward a Proinflammatory State in Egyptian Patients: A Cross-Sectional Study |
Mohamed L. Salem, Madonna M. Eltoukhy, Rasha E. Shalaby, Kamal M. Okasha, Mohamed R. El-Shanshoury, Mohamed A. Attia, Mohamed S. Hantera, Asmaa Hilal, Mohammed A. Eid |
| 15 |
[GO] |
2023―May―30 |
Autoantibodies Neutralizing Type III Interferons Are Uncommon in Patients with Severe Coronavirus Disease 2019 Pneumonia |
Martti Vanker, Karita Särekannu, Arnaud Fekkar, Sofie Eg Jørgensen, Liis Haljasmägi, Anne Kallaste, Kalle Kisand, Margus Lember, Pärt Peterson, Madhvi Menon, Tracy Hussell, Sean Knight, James Moore-Stanley, Paul Bastard, Shen-Ying Zhang, Trine H. Mogensen, Quentin Philippot, Qian Zhang, Anne Puel, Jean-Laurent Casanova, Kai Kisand |
| 16 |
[GO] |
2023―Apr―27 |
A Specific Pattern and Dynamics of Circulating Cytokines Are Associated with the Extension of Lung Injury and Mortality in Colombian Adults with Coronavirus Disease-19 |
Sara Bolívar-Marín, Marcela Castro, Diego Losada-Floriano, Santiago Cortés, Federico Perdomo-Celis, Giovani Lastra, Carlos F. Narváez |
| 17 |
[GO] |
2023―Apr―17 |
The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical) |
Mina Ghofrani Nezhad, Giti Jami, Omid Kooshkaki, Sajjad Chamani, Ali Naghizadeh |
| 18 |
[GO] |
2023―Feb―16 |
The Role of Interferons in Long Covid Infection |
Mohammad Karbalaeimahdi, Safar Farajnia, Nasrin Bargahi, Farzaneh Ghadiri-Moghaddam, Hamid Reza Rasouli Jazi, Nasim Bakhtiari, Samaneh Ghasemali, Nosratollah Zarghami |
| 19 |
[GO] |
2022―Dec―01 |
Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence |
Thomas Hach, Kasra Shakeri-Nejad, Marc Bigaud, Frank Dahlke, Massimiliano de Micco, Olivier Petricoul, Gordon Graham, Daniela Piani-Meier, Renato Turrini, Volker Brinkmann, Ferdinando Nicoletti |
| 20 |
[GO] |
2022―Sep―30 |
Can the Prognosis of COVID-19 Disease Be Determined by Fecal Markers and Cytokines? |
Ahsen Dönmez Türkmen, Gülçin Ünlü, Gulustan Musayeva, Erkan Akkuş, Aybüke Gurup Özen, Pınar Önal, Mert Kuşkucu, Kenan Midilli, Ayse Ayzıt Kılınç, Haluk Çokuğraş, Fügen Çullu Çokuğraş, Ömer Faruk Beşer |
| 21 |
[GO] |
2022―Aug―19 |
The Role of Inflammasomes in COVID-19: Potential Therapeutic Targets |
Chen Sun, Hangyuan Zhao, Yunze Han, Yiqing Wang, Xiao Sun |
| 22 |
[GO] |
2022―Aug―12 |
Analysis of Chitinase-3-Like Protein 1, IL-1-Alpha, and IL-6 as Novel Inflammatory Biomarkers for COVID-19 |
Emine Parlak, Esra Laloğlu |
| 23 |
[GO] |
2022―Jun―16 |
Differential Leukocyte Expression of IFITM1 and IFITM3 in Patients with Severe Pandemic Influenza A(H1N1) and COVID-19 |
Nora E. Regino-Zamarripa, Gustavo Ramírez-Martínez, Luis Armando Jiménez-Álvarez, Alfredo Cruz-Lagunas, Itzel Alejandra Gómez-García, Sergio Ignacio-Cortés, José Eduardo Márquez-García, Lynette Miroslava Pacheco-Hernández, Jazmín Ariadna Ramírez-Noyola, Rodrigo Barquera, Criselda Mendoza-Milla, Cesar Luna-Rivero, José Guillermo Domínguez-Cherit, Remedios Ramírez-Rangel, Tatiana Sofía Rodríguez-Reyna, Carmen M. Hernández-Cárdenas, José Alberto Choreño-Parra, Gloria León-Ávila, Joaquín Zúñiga |
| 24 |
[GO] |
2022―Jun―08 |
Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza |
Lynette Miroslava Pacheco-Hernández, Jazmín Ariadna Ramírez-Noyola, Itzel Alejandra Gómez-García, Sergio Ignacio-Cortés, Joaquín Zúñiga, José Alberto Choreño-Parra |
| 25 |
[GO] |
2022―Jun―08 |
Emergency Hematopoiesis in the Pathobiology of COVID-19: The Dark Side of an Early Innate Protective Mechanism |
Juan Carlos Balandrán, Gabriela Zamora-Herrera, Rubí Romo-Rodríguez, Rosana Pelayo |
| 26 |
[GO] |
2022―Jun―01 |
Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae |
Gustavo Ramírez-Martínez, Luis Armando Jiménez-Álvarez, Alfredo Cruz-Lagunas, Sergio Ignacio-Cortés, Itzel Alejandra Gómez-García, Tatiana Sofia Rodríguez-Reyna, José Alberto Choreño-Parra, Joaquín Zúñiga |
| 27 |
[GO] |
2022―May―13 |
Levels of Vascular Endothelial Growth Factor and Its Association with Pulmonary Embolism in COVID-19 |
Jazmin A. Guerra-López, Luis M. Amezcua-Castillo, Héctor González-Pacheco, Luis M. Amezcua-Guerra |
| 28 |
[GO] |
2021―Dec―22 |
Cutting-Edge Research in COVID-19 and General Viral Immunology |
Paul G. Thomas, Katherine Kedzierska |
| 29 |
[GO] |
2021―Nov―17 |
The Impact of IFNλ4 on the Adaptive Immune Response to SARS-CoV-2 Infection |
Michelle Møhlenberg, Ida Monrad, Line K. Vibholm, Stine S.F. Nielsen, Giacomo Schmidt Frattari, Mariane Høgsbjerg Schleimann, Rikke Olesen, Mads Kjolby, Jesper Damsgaard Gunst, Ole Schmeltz Søgaard, Thomas R. O'Brien, Martin Tolstrup, Rune Hartmann |
| 30 |
[GO] |
2021―Jul―19 |
Quantitative Insight into Immunopathology of SARS-CoV-2 Infection |
Bhavnita Soni, Ritika Kabra, Shailza Singh |
| 31 |
[GO] |
2021―Jun―23 |
Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses |
Thomas Kehrer, Adolfo García-Sastre, Lisa Miorin |
| 32 |
[GO] |
2021―Apr―22 |
Linkage of Lambda Interferons in Protection Against Severe COVID-19 |
Mehdi Shahbazi, Parviz Amri Maleh, Mojgan Bagherzadeh, Zahra Moulana, Mahdi Sepidarkish, Maryam Rezanejad, Mohammad Mirzakhani, Soheil Ebrahimpour, Hosein Ghorbani, Zahra Ahmadnia, Mostafa Javanian, Masomeh bayani, Mousa Mohammadnia-Afrouzi |
| 33 |
[GO] |
2021―Feb―23 |
Perspectives on Targeting IL-6 as a Potential Therapeutic Strategy for COVID-19 |
Yordan Khaedir, Rona Kartika |
| 34 |
[GO] |
2020―Dec―18 |
Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review |
Benjamin M. Liu, Harry R. Hill |
| 35 |
[GO] |
2020―Dec―18 |
Therapeutic Effectiveness of Interferon Alpha 2b Treatment for COVID-19 Patient Recovery |
Ricardo Pereda, Daniel González, Hubert Blas Rivero, Juan Carlos Rivero, Albadio Pérez, Lissette Del Rosario Lopez, Natacha Mezquia, Rafael Venegas, Julio Roberto Betancourt, Rodolfo Emilio Domínguez, Hugo Nodarse |
| 36 |
[GO] |
2020―Dec―18 |
Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2 |
Hongjie Xia, Pei-Yong Shi |
| 37 |
[GO] |
2020―Sep―22 |
Therapeutic Effectiveness of Interferon-α2b Against COVID-19: The Cuban Experience |
Ricardo Pereda, Daniel González, Hubert Blas Rivero, Juan Carlos Rivero, Albadio Pérez, Lissette Del Rosario López, Natacha Mezquia, Rafael Venegas, Julio Roberto Betancourt, Rodolfo Emilio Domínguez |
| 38 |
[GO] |
2020―Sep―03 |
Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin |
Urooj Fatima, Syed Saif Abbas Rizvi, Saher Fatima, Md. Imtaiyaz Hassan |
| 39 |
[GO] |
2020―Aug―13 |
A Geroscience Approach to Preventing Pathologic Consequences of COVID-19 |
Yan Dou, Soroosh Fatemi, Martin Darvas, Michael Gale, Warren Ladiges |
| 40 |
[GO] |
2020―Aug―03 |
COVID-19, Mitochondria, and Interferon |
Pankaj Prasun |
|
